QTREX Quantum Ltd., engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure and advanced connectivity solutions for the quantum computing industry in Israel and USA. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. It also offers HYLA blood sensor, which is designed to perform real-time sampling and analysis of key blood parameter measurements. In addition, The company offers cryogenic interconnects systems are generally built from multiple discrete components assembled and verified in a manual process. It also develops a monolithic interconnect architecture that integrates the conductor, radio-frequency dielectric, shielding, thermal management, and mechanical routing into a single engineered structure, designed to replace discrete, manually assembled cabling and support higher channel density and reliability. In addition, It offers AME Platform, provides the manufacturing foundation for our quantum connectivity development efforts and also operates as a commercial business serving customers across aerospace, missile, defense, and advanced electronics sectors. Further, the company operates as a developer of high-performance software, ink delivery systems, and printhead drive electronics for industrial print systems. The company was formerly known as Inspira Technologies Oxy B.H.N. Ltd. and changed its name to QTREX Quantum Ltd. in May 2026. QTREX Quantum Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.…
Nano Dimension Announces Divestiture of Global Inkjet Systems to QTREX Quantum in $16 Million Equity Transaction
QTREX Quantum (NASDAQ: QTEX) is listed on Nasdaq, where its shares trade in USD. It belongs to the Computer Hardware industry, part of the Technology sector, and reports about 34 employees.
The shares were at 1.000 USD on 20 November 2026, down 2.9% over 52 weeks. Its 52-week range is 0.2830 USD to 3.850 USD: the price is 74.0% below the high and 253.4% above the low.
Its market capitalisation is 70.63M USD.
QTREX Quantum reports revenue up 437.7% year over year.
It holds more cash than debt, a net cash position of 7.87M USD. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health.
No upcoming events tracked.